DETERMINATION OF GENETIC PREDISPOSITION TO AGGRESSIVE PROSTATE CANCER

摘要

The present disclosure relates to prostate cancer-associated genetic markers, namely HOXB13 rs138213197 and CIP2A rs2278911. Methods are disclosed of predicting, diagnosing and/or prognosing prostate cancer, such as a clinically relevant, aggressive form of prostate cancer, in a subject through determining his HOXB13 rs138213197 and CIP2A rs2278911 genotype. Different uses of the method, and a test kit for use in the method are disclosed.